Cargando…

IgG-class anti-PF4/heparin antibodies and symptomatic DVT in orthopedic surgery patients receiving different anti-thromboembolic prophylaxis therapeutics

BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a thromboembolic complication that can occur with unfractionated heparin (UFH) or low molecular weight heparin (LMWH). Our objective was to determine and compare the incidence of IgG-class HIT antibodies in patients undergoing total hip arthropla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motokawa, Satoru, Torigoshi, Takafumi, Maeda, Yumi, Maeda, Kazushige, Jiuchi, Yuka, Yamaguchi, Takayuki, Someya, Shinsuke, Shindo, Hiroyuki, Migita, Kiyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224260/ https://www.ncbi.nlm.nih.gov/pubmed/21261941 http://dx.doi.org/10.1186/1471-2474-12-22

Ejemplares similares

Clinical relevance of heparin-PF4 complex antibody in DVT after total joint replacement
por: Torigoshi, Takafumi, et al.
Publicado: (2009)

CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
por: Migita, Kiyoshi, et al.
Publicado: (2011)

Reduced induction of anti-PF4/heparin antibody in RA patients after total knee arthroplasty
por: Izumi, Masahiro, et al.
Publicado: (2016)

Serum amyloid A triggers the mosodium urate -mediated mature interleukin-1β production from human synovial fibroblasts
por: Migita, Kiyoshi, et al.
Publicado: (2012)

Anti-PF4 VITT antibodies are oligoclonal and variably inhibited by heparin
por: Singh, B, et al.
Publicado: (2021)

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
por: Yamada, Norikazu, et al.
Publicado: (2015)

Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+ )T lymphocyte cytokine production
por: Migita, Kiyoshi, et al.
Publicado: (2011)

Erratum to: ‘Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program’
por: Yamada, Norikazu, et al.
Publicado: (2016)

Deep Vein Thrombosis (DVT) Prophylactic Team Activity to Support DVT Prevention Protocol for the Purpose of the Prophylaxis of Pulmonary Thromboembolism (PTE) and Operation
por: Tamura, Shozo, et al.
Publicado: (2021)

Usefulness of anti-PF4/heparin antibody test for intensive care unit patients with thrombocytopenia
por: Park, Sang Hyuk, et al.
Publicado: (2012)

Current Perspectives on Diagnostic Assays and Anti-PF4 Antibodies for the Diagnosis of Heparin-Induced Thrombocytopenia
por: Sahu, Kamal K, et al.
Publicado: (2020)

Effects of a Foot Pump on the Incidence of Deep Vein Thrombosis After Total Knee Arthroplasty in Patients Given Edoxaban: A Randomized Controlled Study
por: Sakai, Tatsuya, et al.
Publicado: (2016)

Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study
por: Migita, Kiyoshi, et al.
Publicado: (2014)

Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study
por: Lasocki, Sigismond, et al.
Publicado: (2008)

Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
por: Kelly, Julie, et al.
Publicado: (2021)

COVID‐19 patients often show high‐titer non‐platelet‐activating anti‐PF4/heparin IgG antibodies
por: Brodard, Justine, et al.
Publicado: (2021)

Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
por: Paciullo, Francesco, et al.
Publicado: (2020)

Heparin beyond anti-coagulation
por: Chen, Daohong
Publicado: (2021)

Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
por: Nguyen, Lily, et al.
Publicado: (2023)

Spinal anesthesia increases the risk of venous thromboembolism in total arthroplasty: Secondary analysis of a J-PSVT cohort study on anesthesia
por: Nakamura, Mashio, et al.
Publicado: (2017)

Incidence of Symptomatic Vertebral Fractures Among Newly Diagnosed Autoimmune Diseases Initiating Glucocorticoid Therapy
por: Migita, Kiyoshi, et al.
Publicado: (2015)

The Contribution of SAA1 Polymorphisms to Familial Mediterranean Fever Susceptibility in the Japanese Population
por: Migita, Kiyoshi, et al.
Publicado: (2013)

Determining the anti-coagulant-independent anti-cancer effects of heparin
por: Solari, V, et al.
Publicado: (2010)

Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia
por: Prechel, M Margaret, et al.
Publicado: (2013)

Diagnosis of DVT in the emergency department: adherence to guidelines
por: Skjærbæk, Christian
Publicado: (2012)

Emergency Physician Performed Ultrasound for DVT Evaluation
por: Fox, John Christian, et al.
Publicado: (2011)

DVT prophylaxis in critical care: role of NOACS
por: Lancé, Marcus D.
Publicado: (2019)

Thromboelastography for the Prevention of Perioperative Venous Thromboembolism in Orthopedics
por: Fan, Dejing, et al.
Publicado: (2022)

Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT
por: Singh, Bandana, et al.
Publicado: (2021)

Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
por: Prins, Martin H, et al.
Publicado: (2013)

Profile of patients diagnosed with acute venous thromboembolism in routine practice according to age and renal function: RE-COVERY DVT/PE study
por: Ageno, Walter, et al.
Publicado: (2020)

Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia
por: Derhaschnig, U, et al.
Publicado: (2002)

The rate of missed diagnosis of lower-limb DVT by ultrasound amounts to 50% or so in patients without symptoms of DVT: A meta-analysis
por: Zhang, Yuhong, et al.
Publicado: (2019)

Use of Prestudy Heparin Did Not Influence the Efficacy and Safety of Rivaroxaban in Patients Treated for Symptomatic Venous Thromboem‐bolism in the EINSTEIN DVT and EINSTEIN PE Studies
por: Prandoni, Paolo, et al.
Publicado: (2015)

Fondaparinux sodium and low molecular weight heparin for venous thromboembolism prophylaxis in Chinese patients with major orthopedic surgery or trauma: a real-world study
por: Fu, Donglin, et al.
Publicado: (2022)

Molecular Mechanism of the Anti-Inflammatory Action of Heparin
por: Litov, Leandar, et al.
Publicado: (2021)

Diagnosis of DVT in the emergency department: time spent on diagnosis
por: Skjærbæk, Christian
Publicado: (2012)

DVT Surveillance Program in the ICU: Analysis of Cost-Effectiveness
por: Malhotra, Ajai K., et al.
Publicado: (2014)

Is There Any Association between PEEP and Upper Extremity DVT?
por: Al-Saffar, Farah, et al.
Publicado: (2015)

Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody test
por: Hron, Gregor, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4ghmdr0pfu3hq7chl0i6jlqsa1